Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

SPINEWAY : Continued expansion in the USA New distributor in Texas

Posted on: 07 Sep 17

Press release                                                                                                                                                                   Ecully, 7 September 2017

Continued expansion in the USA
New distributor in Texas

Spineway, specialist in surgical implants and instruments for treating disorders of the spinal column (spine), has just signed its fourth distribution agreement in the USA with a distributor in Texas.

Established over 20 years ago, this new partner has a significant network in Texas and a solid understanding of the spinal surgery market. Its sales revenue exceeds 10 million dollars. Its large client portfolio provides Spineway with interesting prospects for its continued development.

Thanks to this new distributor, the Group's US subsidiary is strengthening its position as it progressively increases its coverage of the US territory.

Find out all about Spineway at

Next communication:
2017 First Semester Results - 26 October 2017, after market closes

Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.
Spineway has an international network of over 50 independent distributors and 90% of its turnover comes from exports.
Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), received the OSEO Excellence award as well as the Deloitte Fast 50 award in 2011. Rhône Alpes INPI Patent Innovation Award (2013) - Talent INPI award (2015).
ISIN code: FR0011398874 - Euronext Growth


Investor Relations
David Siegrist - Finance Director
+33 (0)4 72 77 01 52
  Financial Communication
Jérôme Gacoin / Solène Kennis
+33 (0)1 75 77 54 68
Continued expansion in the USA New distributor in Texas

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: SPINEWAY via GlobeNewswire

Last updated on: 08/09/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.